Protective effect of histidine on MPP+-induced hydroxyl radical generation in rat striatum

Brain Research

Volumn 817, Issue 1-2, 1999, Pages 206-208

  Obata, Toshio ^a   Inada, Toshiya ^b  

^a OITA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

1 Methyl 4 phenylpyridinium ion (MPP+); Free radical; Histidine; Microdialysis; Parkinson's disease

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 2,3 DIHYDROXYBENZOIC ACID; HISTIDINE; HYDROXYL RADICAL; SALICYLATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; CORPUS STRIATUM; MALE; MICRODIALYSIS; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CORPUS STRIATUM; HALF-LIFE; HISTIDINE; HYDROXYL RADICAL; MALE; NEUROPROTECTIVE AGENTS; NEUROTOXINS; RATS; RATS, WISTAR;

EID: 0033616363     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01225-6     Document Type: Article

References (28)

1. Ben-Shachar D., Youdim M.B.H. Intranigral iron injection induces behavioral and biochemical 'parkinsonism' in rats. J. Neurochem. 57:1991;2133-2135.
2. Chevion M. A site-specific mechanism for free radical induced biological damage: the essential role of redox-active transition metals. Free Radic. Biol. Med. 5:1988;27-37.
3. Chiba K., Frevor A.J., Castagnoli Jr. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. Res. Commun. 120:1984;574-578.
4. +. Free Radic. Biol. Med. 13:1992;581-583.
5. Chiueh C.C., Miyake H., Peng M.T. Role of dopamine autooxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism. Adv. Neurol. 60:1993;251-258.
6. Dexter D.T., Carter C.J., Wells F.R., Javoy-Agid F., Agid Y., Lees A., Jenner P., Marsden C.D. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52:1989;381-389.
7. Feix J.B., Kalyanaraman B. Production of singlet oxygen-derived hydroxyl radical adducts during merocyanine-540-mediated photosensitization: analysis by ESR-spin trapping and HPLC with electrochemical detection. Arch. Biochem. Biophys. 291:1991;43-51.
8. Floyd R.A., Watson J.J., Wong P.K. Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products. J. Biochem. Biophys. Methods. 10:1984;221-235.
9. Halliwell B., Gutteridge J.M. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 219:1984;1-14.
10. Halliwell B. Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, traumatic injury, or stroke? Acta Neurol. Scand. Suppl. 126:1989;23-33.
11. Halliwell B. Reactive oxygen species and central nervous system. J. Neurochem. 59:1992;1609-1623.
12. Halliwell B., Kaur H., Ingleman-Sundberg M. Hydroxylation of salicylate as an assay for hydroxyl radicals: a cautionary note. Free Radic. Biol. Med. 10:1991;439-441.
13. Hearse D.J., Kusama Y., Bernier M. Rapid electrophysiological changes leading to arrhythmia in the aerobic rat heart: photosensitivization studies with rose bengal-derived reactive oxygen intermediates. Circ. Res. 65:1989;146-153.
14. Hirsch E., Graybiel A.M., Agid Y.A. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature (Lond.). 334:1988;345-348.
15. Kalyanaraman B., Feix J.B., Sieber F., Thomas J.P., Girotti A.W. Photodynamic action of merocyanine 540 on artificial and natural cell membranes: involvement of singlet molecular oxygen. Proc. Natl. Acad. Sci. U.S.A. 84:1987;2999-3003.
16. Kukreja R.C., Loesser K.E., Kearns A.A., Naseem S.A., Hess M.L. Protective effects of histidine during ischemia-reperfusion in isolated perfused rat hearts. Am. J. Physiol. 264:1993;H1370-H1381.
17. +): identification of a metabolite of MPTP, a toxin selective to the substantia nigra. Neurosci. Lett. 48:1984;87-92.
18. Markey S.P., Schmuff N.R. The pharmacology of the parkinsonian syndrome producing neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and structurally related compounds. Med. Res. Rev. 6:1986;389-429.
19. Maruyama W., Dostert P., Naoi M. Dopamine-derived 1-methyl-6,7-dihydroxyisoquinolines as hydroxyl radical promoters and scavengers in the rat brain: in vivo and in vitro studies. J. Neurochem. 64:1995;2635-2643.
20. Obata T., Hosokawa H., Yamanaka Y. In vivo monitoring of norepinephrine and ·OH generation on myocardial ischemic injury by dialysis technique. Am. J. Physiol. 266:1994;H903-H908.
21. G. Paxinos, C. Watson, The Rat Brain Stereotaxic Coordinates, 2nd edn., Academic Press, Sydney, 1982.
22. Riederer P., Sofic E., Rausch W.-D., Schmidt B., Reynolds G.P., Jellinger K., Youdim M.B.H. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52:1989;515-520.
23. Suzuki Y., Sudo J.I. Lipid peroxidation and generations of oxygen radicals induced by cephaloridine in renal cortical microsomes of rats. Jpn. J. Pharmacol. 52:1990;233-243.
24. Takemura G., Onodera T., Ashraf M. Quantification of hydroxyl radical and its lack of relevance to myocardial injury during early reperfusion after graded ischemia in rat heart. Circ. Res. 71:1992;96-105.
25. Wefers H., Schulte-Frohlinde D., Sies H. Loss of transforming activity of plasmid DNA (pBR322) in E. coli caused by singlet molecular oxygen. FEBS Lett. 211:1987;49-52.
26. Zhai X., Ashraf M. Direct detection and quantification of singlet oxygen during ischemia and reperfusion in rat hearts. Am. J. Physiol. 269:1995;1229-1236.
27. Zs-Nagy I., Floyd R.A. Hydroxyl free radical reactions with amino acids and proteins studies by electron spin resonance spectroscopy and spin trapping. Biochim. Biophys. Acta. 790:1984;238-250.
28. Youdim M.B.H., Ben-Shachar D., Riederer P. Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration? Acta Neurol. Scand. 126:1989;47-54.